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Objectives: To assess the COVID-19 associated fatalities with respect to demographics, comorbidity, critical 
illness, and length of hospital stay in tertiary care hospitals. 
Subjects & Methods: A retrospective hospital data-based research was done among 216 COVID-19 associated 
mortalities registered in 4 tertiary care hospitals Holy Family Hospital (HFH), Benazir Bhutto Hospital (BBH), 
District Head Quarters Hospital (DHQ) and Rawalpindi Institute of Urology & Transplantation (RIU & T) 
affiliated with Rawalpindi Medical University from 29th March-15th June 2020. The data was gathered by 
consecutive sampling pertinent to demographics, hospital stay, comorbidity, critical illness, and ventilator or 
oxygen support. The length of hospital stay among fatalities with and without comorbidity was compared by an 
independent sample z-test. Data were analyzed by using SPSS version 25.0.  
Results: Of the total 216 COVID-19 related mortalities, 150(69.4%) were males and 66(30.6%) were females. The 
mean age of fatalities was 55.66 ± 13.97 years. About 76.7% of dying males were 41-70 years old while 56.1% of 
females dying of COVID-19 were 41-60 years old. Most (60.8%) of study subjects had hypertension followed by 
diabetes (53.8%), Ischemic Heart Disease (17.5%), and respiratory disorders (12.3%). About 75% of the critically ill 
patients needed a ventilator for respiratory support. Length of hospital stay was determined to have a statistically 
insignificant association (P > 0.10) with the presence or absence of comorbidity among COVID-19 patients. Critical 
illness had a highly significant association (P < 0.000) with ventilator support among COVID-19 related 
mortalities. 
Conclusion: People 41-70 years should preferably adopt stringent precautions for protection against COVID-19. 
Comorbid states chiefly hypertension, diabetes, cardiac and respiratory diseases need special consideration amid 
COVID-19 pandemic to abstain from adverse health outcomes.  
Keywords: COVID-19, tertiary care hospitals, ventilator, diabetes, hypertension, comorbidity, Ischemic Heart 
Disease.   
 
 
33                                              Journal of Rawalpindi Medical College (JRMC); 2020; 24 COVID-19 Supplement-1: 32-36 
Introduction 
 
The world is confronted with new challenges owing to 
the rapid person to person transmission of coronavirus 
infection.1 Due to the novelty of coronavirus, very little 
authentic information is known to the public pertinent 
to its transmission, prevention, and treatment, thus 
attributing to escalating mortalities across the world.2 
Uncontrolled spread of COVID-19 across the borders3 
and its unclear coverage are major contributors to 
grave health outcomes and poor socio-economic 
effects.4 World Health Organization declared COVID-
19 as pandemic on 11th March 2020 due to its gigantic 
spread5 that has encompassed about 213 countries 
across the globe with approximately 8,406,195 
confirmed cases and 451,387 mortalities till 19th June 
2020.6 The first COVID-19 case was reported in 
Karachi on 26th March 2020.7 Around 160,000 
confirmed COVID-19 cases have emerged in Pakistan 
till Mid-June 2020 with peak figure (55,878 cases) 
reported in Punjab province illustrating approximately 
3093 deaths.8  
COVID-19 cases present with mild to severe clinical 
manifestations.9 Therefore patient management is also 
quite diverse ranging from ward-based care to oxygen 
provision in high dependency unit and even reliance 
on ventilators in case of severe respiratory distress.10 
Attributes of coronavirus infected patients like age and 
comorbidity are determined to have some influence on 
the seriousness of disease and duration of hospital 
stay.11,12 According to the World Health Organization, 
about 80% of COVID-19 cases are likely to have a mild 
illness, 14% of patients are presenting with severe 
symptoms while 6% are categorized as critically ill. 
Keeping in view the wide spectrum of clinical 
manifestations among COVID-19 cases, vigorous risk 
assessment among people is of paramount significance 
for prompt clinical management.13 Apart from the 
spectrum of this illness, the inability to test the whole 
population estimated the actual number of COVID-19 
cases impossible. The deaths are also underrated due 
to the non-hospitalization of the patients or hiding of 
disease.14  
The present study is primarily carried out to verify the 
key characteristics of COVID-19 related fatalities 
among the Pakistani population. The data of COVID-
19 mortalities was therefore scrutinized from all 4 
tertiary care hospitals affiliated with Rawalpindi 
Medical University. This research would prove very 
significant in planning the level of healthcare 
provision to COVID-19 patients in accordance with 
their demographics and comorbid states. 
Materials and Methods 
 
A retrospective hospital data-based study was 
conducted among 216 fatalities reported in four 
tertiary care hospitals namely Holy Family Hospital 
(HFH), Benazir Bhutto Hospital (BBH), District Head 
Quarters Hospital (DHQ) and Rawalpindi Institute of 
Urology & Transplantation (RIU & T) affiliated with 
Rawalpindi Medical University Rawalpindi. The data 
was collected by consecutive sampling pertinent to 
date of admission and expiry, demographics, length of 
hospital stay, comorbidity and ventilator or oxygen 
support among COVID-19 associated fatalities. Data 
was entered and analyzed using SPSS version 25.0. 
STATISTICAL ANALYSIS 
Frequency and percentage were calculated for gender. 
Mean ± Standard Deviation was computed for 
continuous variables like age and length of hospital 
stay. The mean duration of hospital stay among 
fatalities with and without comorbidity was evaluated 
by an Independent sample z-test. Association of 
critical illness with the need for ventilators among 
COVID-19 fatalities was determined by Fisher’s Exact 




Of the total 216 COVID-19 related mortalities reported 
in the four tertiary care hospitals affiliated with 
Rawalpindi Medical University, 150(69.4%) were 
males and 66(30.6%) were females. The trend pertinent 




Figure 1: COVID-19 related Mortality Trend in four 
tertiary care hospitals of RMU 
The mean age of dead patients was reported to be 
55.66 ± 13.97 years. The gender-based distribution of 
these deaths from each hospital is reflected below in 
Figure 2. 
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Figure 2: Gender-based distribution of fatalities 
from tertiary care hospitals of RMU 
Table 1: Age-based distribution of COVID-19 related 
mortality in both genders 
Age groups Males Females Total 
1-10 years 0 01 01 
11-20 years 02 01 03 
21-30 years 03 07 10 
31-40 years 10 05 15 
41-50 years 30 19 49 
51-60 years 39 18 57 
61-70 years 46 12 58 
71-80 years 15 03 18 
81-90 years 05 0 05 
Total 150 66 216 
 
The proportion of COVID-19 related mortality was 
also greater among males as illustrated in Figure 3. 
 
Figure 3: Gender-based COVID-19 related 
Mortalities from March -June 2020 
Of the total 216 fatalities enrolled in our research, 171 
(79.2%) were determined to have comorbidity with 
hypertension representing the highest frequency that 
is 104(60.8%), followed by diabetes 92(53.8%), 
Ischemic Heart Disease 30(17.5%), Respiratory 
Disorders 21(12.3%), Chronic Liver Diseases 16(9.3%) 
and Chronic Kidney Disease 12(7%). Also, 8(4.7%) 
were smokers, 5(2.9%) had a psychiatric illness and 
4(2.3%) were obese. Comorbidity among study 
subjects is categorized as shown below in Figure 4.  
 
Figure 4: Grouping of co-morbidities among COVID-
19 related fatalities in tertiary care hospitals of RMU 
(n = 171) 
The mean duration of hospital stay among our study 
participants was determined to be 6.54 ± 6.04 days. 
Statistical difference in length of hospital stay among 
COVID-19 fatalities with and without comorbidity is 
shown below in Table 2.  
Table 2: Statistical difference in mean length of 
hospital stay among COVID-19 related Mortalities  
(n = 216) 
Mean length of hospital stay P-value 
Mortalities with 
comorbidity 
 (n = 45) 
Mortalities without 
any comorbidty  
(n = 171) 
8.13 ± 7.5 days 6.25 ± 7.1  > 0.10 
 
About 131 (75%) out of 175 critically ill study subjects 
had comorbidity. Of the total 175 critically ill fatalities, 
101 were put on ventilators. The critical illness seemed 
to have a highly significant association (P < 0.000) with 
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Discussion 
  
COVId-19 is established to be a disease with varied 
symptoms ranging from mild illness to severe 
condition. Early identification of this problem, 
therefore, is of paramount significance for prompt 
management and prevention of grave consequences.15 
Out of a total of 216 COVID-19 associated deaths 
reported in our tertiary care public sector hospitals, the 
majority (69.4%) were males. Similarly, the highest 
proportion of COVID-19 related fatalities in China was 
comprised of their male populates (70.3%).16 The high 
propensity of coronavirus infection among males is an 
aspect that is under research to determine the logic 
behind it. The mean age of COVID-19 related 
mortalities in our research is 55.66 ± 13.97 years. A 
higher proportion of males and females in our study 
were 41-70 years and 41-60 years old respectively. In 
comparison with COVID-19 associated deaths in Italy, 
the mean age was determined to be 79.5 ± 8.1 years. 
Similarly, the highest percentage (30.5%) of COVID-19 
deaths was reported among Chinese17 and Korean 
populates 70-79 years age group.18 Although middle-
aged people in Pakistan are also found to be suffering 
from COVID-19 more or less old age people from any 
race or population might be at higher risk of dying 
from coronavirus infection. The underlying factor 
might be poor immunity among senior citizens of a 
nation. Therefore precautionary measures should be 
religiously adopted by elders to avoid grave health 
consequences. 
Of the total 216 study subjects, the majority (60.8%) of 
COVID-19 related mortalities in our study had 
hypertension, followed by diabetes (53.8%), Ischemic 
Heart Disease (17.5%), and respiratory disorders 
(12.3%). Also, 4.7% were smokers and 2.3% were 
obese. On the other hand, research among 355 Italians 
who died of COVID-19 revealed that their highest 
proportion (35.5%) had diabetes followed by Ischemic 
Heart Disease (30%), atrial fibrillation (24.5%) and 
active cancer (20.3).17 About 20.8% of our study 
subjects dying from COVID-19 and 0.8% from Italy17 
did not have any comorbidity. On analysis of COVID-
19 related fatalities of America, it became evident that 
the majority of them had hypertension (56.6%) 
followed by obesity (41.7%) and diabetes (33.8%).15 
This diversity in the pattern of comorbidity among 
various nations might be due to differences in their 
geographic regions or culture that entails qualitative 
research to explore the root cause of this variance. 
Reviewing the medical record of these patients 
perhaps can also help scrutinize the reason for this 
dissimilarity.  
The mean length of hospital stay among COVID-19 
related fatalities was reported to be 6.54 ± 6.04 days. 
Similarly, the duration of hospital stay among Chinese 
COVID-19 patients admitted in the Intensive care unit 
is computed to be 5-13 days. However, those who died 
had shorter hospital stays than those who survived19. 
Most of the males dying of COVID-19 in our research 
were 41-70 years old while the majority of females 
were 41-60 years old. On the other hand, mostly aged 
people among Chinese populates suffering from 
COVID-19 succumbed to death.20 In contrast to 
Chinese research, middle-aged people affected by 
COVID-19 in Pakistan were also determined to have 
poor health outcomes. This age difference calls for 
further research to scrutinize the rationale. 
About 175 (75%) of the study subjects out of a total of 
216 in the current research were critically ill and 
approximately 101 of these were on ventilators for 
survival. All those puts on ventilators had one or more 
comorbid states. However, 30 study subjects in our 
research despite having comorbidity did not need a 
ventilator and just received oxygen supply. Likewise, 
critically ill COVID-19 cases of the United States had a 
30.9% death rate. About 35.7% of the critically ill 
needed ventilators and higher mortality seemed to be 
primarily associated with diabetes (46.8%), followed 
by cardiac problems (42%) and chronic renal disorder 
(38.7%)21. The dependency of COVID-19 cases on 
respiratory support might be attributed to their 
comorbidity. However, this facet should be rigorously 




Elders with comorbidity are more prone to 
coronavirus infection. More researches among 
different nations would be supportive to pinpoint the 
association of comorbidity with COVID-19 related 
fatalities. 
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